Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
Source: medscape.com
📰 Abandon Current News
Abandon Current News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abandon Current. Real-time updates on events, politics, business and more.